BioSpace News Archive

Drug Development

Pfizer Announces Overall Survival Results from Phase 3 PALOMA-3 Trial of IBRANCE® (Palbociclib) in HR+, HER2- Metastatic Breast Cancer

Results show a positive trend in the secondary endpoint of overall survival, though not reaching statistical significance

June 25, 2018
·
11 min read
Business

Synthetic Genomics Appoints Reinhard J. Ambros, Ph.D., Former Global Head of the Novartis Venture Fund to Board of Directors

Dr. Ambros was the global head of the Novartis Venture Fund from 2005 to 2017 and built one of the largest and most active corporate Biotechnology Venture Funds globally.

June 25, 2018
·
3 min read
Genetown

Kaleido Biosciences Raises $101 Million Series C Financing

Oversubscribed Financing Includes New and Existing Investors

June 25, 2018
·
2 min read
MILabs introduces futuristic PET capabilities on its new VECTor6 system

At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26, MILabs announced innovative new PET features.

June 25, 2018
·
1 min read
Drug Development

Xeris Pharmaceuticals Announces Positive Phase 3 Clinical Trial Data on Its Investigational Ready-to-Use Glucagon Rescue Pen

Results of two Phase 3 studies presented at the American Diabetes Association’s 78th Scientific Sessions

June 25, 2018
·
6 min read
Deals

Mirati Therapeutics Added to Russell 2000® Index

Mirati Therapeutics, Inc. announced that it has been added to the Russell 2000® Index

June 25, 2018
·
3 min read
Business

Building the West Coast team and welcoming Kirk Tousaw and Mat Beren to the Canopy Growth family

Canopy Growth Corporation is pleased to announce the addition of well-respected cannabis industry leaders Kirk Tousaw and Mat Beren to its West Coast bench.

June 25, 2018
·
5 min read
Deals

Palatin Technologies Added to Russell 3000® Index

Palatin Technologies, Inc. announced that it has been added to the Russell 3000® Index as part of the annual Russell U.S. Index reconstitution.

June 25, 2018
·
3 min read
Geneva Protest Tuesday: Picketers to Target UNAIDS’ Sexual Harassment Cover-up Prior to Meeting at WHO

As UNAIDS members arrive for Programme Coordinating Board (PCB) meetings in Geneva, advocates will picket in front of WHO headquarters to call for the dismissal of UNAIDS’ Executive Director Michel Sidibé over his botched handling of a sexual harassment investigation of senior staff at the agency.

June 25, 2018
·
5 min read
Deals

Heron Therapeutics Announces Pricing of Public Offering of Approximately $200 Million of its Common Stock

Heron Therapeutics, Inc. announced the pricing of an underwritten public offering of approximately $200 million of shares of its common stock.

June 25, 2018
·
3 min read